Interim results

Summary by AI BETAClose X

hVIVO plc announced its unaudited interim results for the six months ended 30 June 2025. The company reported revenue of £24.2 million, which includes £5.2 million from CRS and £0.3 million from Cryostore. The EBITDA pre-exceptionals was £3.0 million, with an EBITDA margin of 12.5%. Basic adjusted earnings per share were 0.29p. As of 30 June 2025, hVIVO had cash reserves of £23.3 million and a weighted contracted orderbook of £40 million. Exceptional items, comprising acquisition-related and restructuring costs, totaled £1.4 million. The company expects to deliver full-year revenues of £47 million and a low-single digit EBITDA loss pre-exceptionals.

Disclaimer*

Companies

Hvivo (HVO)
UK 100

Latest directors dealings